[1]黄昀 曲伸.胰高血糖素样肽-2对能量平衡及糖代谢的调节[J].国际内分泌代谢杂志,2015,(05):324-326.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.009]
 Huang Yun,Qu Shen..Regulation of glucagon-like peptide-2 on energy balance and glucose metabolism[J].International Journal of Endocrinology and Metabolism,2015,(05):324-326.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.009]
点击复制

胰高血糖素样肽-2对能量平衡及糖代谢的调节()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2015年05期
页码:
324-326
栏目:
胰高血糖素样肽专题
出版日期:
2015-09-20

文章信息/Info

Title:
Regulation of glucagon-like peptide-2 on energy balance and glucose metabolism
作者:
黄昀 曲伸
200072 上海,同济大学附属上海市第十人民医院内分泌代谢病科
Author(s):
Huang Yun Qu Shen.
Department of Endocrinology, Shanghai 10th People's Hospital, Tongji University, Shanghai 200072, China
关键词:
胰高血糖素样肽-2 能量平衡 糖代谢
Keywords:
Glucagon-like peptide-2 Energy balance Glucose metabolism
DOI:
DOI:10.3760/cma.j.issn.1673-4157.2015.05.009
摘要:
胰高血糖素样肽-2(GLP-2)是一种新型的肠道特异性营养因子,它主要通过GLP-2受体发挥作用。近期研究发现,GLP-2对肠道及中枢存在双重作用,可通过增强肠道营养物质吸收、抑制摄食行为、减缓胃排空、改善餐后血糖及胰岛素敏感性,调节能量平衡和维持糖代谢稳态。
Abstract:
Glucagon-like peptide-2(GLP-2)is known as a new intestinal trophic factor. The actions of GLP-2 are transduced by GLP-2 receptor. Recent researches show that GLP-2 can act on both gastrointestinal tract and central nervous system. GLP-2 can regulate energy balance and glucose homeostasis by enhancing intestinal nutrients absorption, inhibiting feeding behavior, decelerating gastric emptying, and promoting postprandial glycemic control and insulin sensitivity.

参考文献/References:

[1] Marathe CS, Rayner CK, Jones KL, et al.Glucagon-like peptides 1 and 2 in health and disease: a review[J].Peptides,2013,44:75-86. [/br][2] Drucker DJ, Yusta B.Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2[J].Annu Rev Physiol,2014,76:561-583. [/br][3] Vrang N, Larsen PJ. Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides[J].Prog Neurobiol,2010,92(3):442-462. [/br][4] Dalvi PS, Belsham DD.Glucagon-like peptide-2 directly regulates hypothalamic neurons expressing neuropeptides linked to appetite control in vivo and in vitro[J].Endocrinology,2012,153(5):2385-2397. [/br][5] Suzuki K, Simpson AK, Minnion JS, et al.The role of gut hormones and the hypothalamus in appetite regulation[J].Endocr J,2010,57(5):359-372. [/br][6] Lam CK, Chari M, Lam TK.CNS regulation of glucose homeostasis[J].Physiology(Bethesda),2009,24:159-170. [/br][7] Girardet C, Butler AA. Neural melanocortin receptors in obesity and related metabolic disorders[J]. Biochim Biophys Acta,2014,1842(3):482-494. [/br][8] Guan X.The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis[J].Am J Physiol Regul Integr Comp Physiol,2014,307(6):R585-R596. [/br][9] Tang-Christensen M, Larsen PJ, Thulesen J, et al.The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake[J].Nat Med,2000,6(7):802-807. [/br][10] Honda K, Saneyasu T, Shimatani T, et al.Intracerebroventricular administration of chicken glucagon-like peptide-2 potently suppresses food intake in chicks[J].Anim Sci J,2015,86(3):312-318. [/br][11] Guan X, Shi X, Li X, et al.GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility[J].Am J Physiol Endocrinol Metab,2012,303(7):E853-E864. [/br][12] Rossi J, Balthasar N, Olson D, et al.Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis[J].Cell Metab,2011,13(2):195-204. [/br][13] Wang Y, Guan X.GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons[J].Am J Physiol Endocrinol Metab,2010,298(2):E156-E166. [/br][14] Shi X, Zhou F, Li X, et al.Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons[J].Cell Metab,2013,18(1):86-98. [/br][15] Hill JW, Williams KW, Ye C, et al.Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice[J].J Clin Invest,2008,118(5):1796-1805. [/br][16] Sohn JW, Xu Y, Jones JE, et al.Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels[J].Neuron,2011,71(3):488-497. [/br][17] Drozdowski LA, Iordache C, Clandinin MT, et al.Dexamethasone and GLP-2 administered to rat dams during pregnancy and lactation have late effects on intestinal sugar transport in their postweaning offspring[J]. J Nutr Biochem,2008,19(1):49-60. [/br][18] Hsieh J, Longuet C, Maida A, et al.Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36[J].Gastroenterology,2009,137(3):997-1005, 1005. e1-e4. [/br][19] Meier JJ, Nauck MA, Pott A, et al.Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans[J].Gastroenterology,2006,130(1):44-54. [/br][20] Horner KM, Byrne NM, Cleghorn GJ, et al.The effects of weight loss strategies on gastric emptying and appetite control[J].Obes Rev,2011,12(11):935-951. [/br][21] Amato A, Baldassano S, Serio R, et al.Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release[J].Am J Physiol Gastrointest Liver Physiol,2009,296(3):G678-G684. [/br][22] Amato A, Rotondo A, Cinci L, et al.Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon[J]. Am J Physiol Gastrointest Liver Physiol,2010,299(5):G1038-G1044. [/br][23] Bahrami J, Longuet C, Baggio LL, et al.Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse[J]. Gastroenterology,2010,139(3):857-868. [/br][24] Baldassano S, Rappa F, Amato A, et al.GLP-2 as beneficial factor in the glucose homeostasis in mice fed a high fat diet[J]. J Cell Physiol,2015,[Epub ahead of print].

相似文献/References:

[1]龚凡,陆灏.IKKε调节代谢平衡及其机制[J].国际内分泌代谢杂志,2017,37(02):120.[doi:10.3760/cma.j.issn.1673-4157.2017.02.013]
 Gong Fan,Lu Hao..IKKε regulate energy balance and its mechanism[J].International Journal of Endocrinology and Metabolism,2017,37(05):120.[doi:10.3760/cma.j.issn.1673-4157.2017.02.013]

备注/Memo

备注/Memo:
基金项目:2012年中华医学会临床医学科研专项基金(120120550355); 2012上海市卫生局申康慢病综合防治项目(SHDC12012303) 作者单位:200072 上海,同济大学附属上海市第十人民医院内分泌代谢病科 通信作者:曲伸,Email:qushencn@hotmail.com
更新日期/Last Update: 2015-09-20